Logo image of ZKIN

ZK INTERNATIONAL GROUP CO LT (ZKIN) Stock Fundamental Analysis

NASDAQ:ZKIN - Nasdaq - VGG9892K2092 - Common Stock - Currency: USD

2.27  -0.04 (-1.73%)

Fundamental Rating

1

ZKIN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 154 industry peers in the Metals & Mining industry. Both the profitability and financial health of ZKIN have multiple concerns. ZKIN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ZKIN has reported negative net income.
In the past year ZKIN has reported a negative cash flow from operations.
In the past 5 years ZKIN always reported negative net income.
In the past 5 years ZKIN reported 4 times negative operating cash flow.
ZKIN Yearly Net Income VS EBIT VS OCF VS FCFZKIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.48%, ZKIN is in line with its industry, outperforming 40.91% of the companies in the same industry.
ZKIN has a Return On Equity of -9.88%. This is in the lower half of the industry: ZKIN underperforms 62.99% of its industry peers.
Industry RankSector Rank
ROA -3.48%
ROE -9.88%
ROIC N/A
ROA(3y)-37.43%
ROA(5y)-23.21%
ROE(3y)-86.85%
ROE(5y)-53.32%
ROIC(3y)N/A
ROIC(5y)N/A
ZKIN Yearly ROA, ROE, ROICZKIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

ZKIN has a Gross Margin of 6.05%. This is in the lower half of the industry: ZKIN underperforms 62.34% of its industry peers.
ZKIN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ZKIN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.55%
GM growth 5Y-24.34%
ZKIN Yearly Profit, Operating, Gross MarginsZKIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

2

2. Health

2.1 Basic Checks

ZKIN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ZKIN has more shares outstanding
The number of shares outstanding for ZKIN has been increased compared to 5 years ago.
Compared to 1 year ago, ZKIN has an improved debt to assets ratio.
ZKIN Yearly Shares OutstandingZKIN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ZKIN Yearly Total Debt VS Total AssetsZKIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ZKIN has an Altman-Z score of 0.81. This is a bad value and indicates that ZKIN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.81, ZKIN is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
ZKIN has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
ZKIN has a Debt to Equity ratio (0.24) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 0.81
ROIC/WACCN/A
WACC6.41%
ZKIN Yearly LT Debt VS Equity VS FCFZKIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 1.26 indicates that ZKIN should not have too much problems paying its short term obligations.
ZKIN's Current ratio of 1.26 is on the low side compared to the rest of the industry. ZKIN is outperformed by 77.92% of its industry peers.
A Quick Ratio of 0.99 indicates that ZKIN may have some problems paying its short term obligations.
ZKIN has a Quick ratio of 0.99. This is in the lower half of the industry: ZKIN underperforms 67.53% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.99
ZKIN Yearly Current Assets VS Current LiabilitesZKIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 95.90% over the past year.
ZKIN shows a decrease in Revenue. In the last year, the revenue decreased by -3.05%.
ZKIN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.11% yearly.
EPS 1Y (TTM)95.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.71%
Revenue 1Y (TTM)-3.05%
Revenue growth 3Y2.87%
Revenue growth 5Y11.11%
Sales Q2Q%-10.71%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZKIN Yearly Revenue VS EstimatesZKIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ZKIN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZKIN Price Earnings VS Forward Price EarningsZKIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZKIN Per share dataZKIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZKIN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZK INTERNATIONAL GROUP CO LT

NASDAQ:ZKIN (6/17/2025, 11:17:39 AM)

2.27

-0.04 (-1.73%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)09-29 2025-09-29
Inst Owners0.41%
Inst Owner Change-99.19%
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap11.71M
Analysts0
Price TargetN/A
Short Float %5.13%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.42
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)-0.54
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.45
FCFYN/A
OCF(TTM)-1.33
OCFYN/A
SpS20.97
BVpS5.46
TBVpS5.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.48%
ROE -9.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.05%
FCFM N/A
ROA(3y)-37.43%
ROA(5y)-23.21%
ROE(3y)-86.85%
ROE(5y)-53.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.55%
GM growth 5Y-24.34%
F-Score3
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 71.01%
Cap/Sales 0.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 0.99
Altman-Z 0.81
F-Score3
WACC6.41%
ROIC/WACCN/A
Cap/Depr(3y)148.95%
Cap/Depr(5y)182.32%
Cap/Sales(3y)1.56%
Cap/Sales(5y)1.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.71%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.05%
Revenue growth 3Y2.87%
Revenue growth 5Y11.11%
Sales Q2Q%-10.71%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y84.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-260.91%
OCF growth 3YN/A
OCF growth 5YN/A